These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 22934705

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R, Yu Z, Chen F, Xu H, Shen S, Chen W, Chen L, Su Q, Zhang L, Bi J, Zeng W, Li W, Huang X, Wang Q.
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [Abstract] [Full Text] [Related]

  • 25. Role of growth factor receptor bound protein 7 in hepatocellular carcinoma.
    Itoh S, Taketomi A, Tanaka S, Harimoto N, Yamashita Y, Aishima S, Maeda T, Shirabe K, Shimada M, Maehara Y.
    Mol Cancer Res; 2007 Jul; 5(7):667-73. PubMed ID: 17634422
    [Abstract] [Full Text] [Related]

  • 26. Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation.
    Chen KF, Yu HC, Liu TH, Lee SS, Chen PJ, Cheng AL.
    J Hepatol; 2010 Jan; 52(1):88-95. PubMed ID: 19913321
    [Abstract] [Full Text] [Related]

  • 27. Krüppel‑like factor expression and correlation with FAK, MMP‑9 and E‑cadherin expression in hepatocellular carcinoma.
    Han S, Han L, Sun H, Zan X, Zhou Z, Xu K, Yao Y, Liu Q.
    Mol Med Rep; 2013 Jul; 8(1):81-8. PubMed ID: 23670717
    [Abstract] [Full Text] [Related]

  • 28. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.
    Chen JS, Li HS, Huang JQ, Dong SH, Huang ZJ, Yi W, Zhan GF, Feng JT, Sun JC, Huang XH.
    Cancer Lett; 2016 May 28; 375(1):73-83. PubMed ID: 26944318
    [Abstract] [Full Text] [Related]

  • 29. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.
    Zheng L, Yang W, Wu F, Wang C, Yu L, Tang L, Qiu B, Li Y, Guo L, Wu M, Feng G, Zou D, Wang H.
    Clin Cancer Res; 2013 Oct 01; 19(19):5372-80. PubMed ID: 23942093
    [Abstract] [Full Text] [Related]

  • 30. Krüppel-like factor 8 regulates VEGFA expression and angiogenesis in hepatocellular carcinoma.
    Cheng S, Zhang X, Xu Y, Dai X, Li J, Zhang T, Chen X.
    Sci Rep; 2018 Nov 27; 8(1):17415. PubMed ID: 30479372
    [Abstract] [Full Text] [Related]

  • 31. Focal adhesion kinase: important to prostaglandin E2-mediated adhesion, migration and invasion in hepatocellular carcinoma cells.
    Bai XM, Zhang W, Liu NB, Jiang H, Lou KX, Peng T, Ma J, Zhang L, Zhang H, Leng J.
    Oncol Rep; 2009 Jan 27; 21(1):129-36. PubMed ID: 19082453
    [Abstract] [Full Text] [Related]

  • 32. FAK is involved in invasion and metastasis of hepatocellular carcinoma.
    Chen JS, Huang XH, Wang Q, Chen XL, Fu XH, Tan HX, Zhang LJ, Li W, Bi J.
    Clin Exp Metastasis; 2010 Feb 27; 27(2):71-82. PubMed ID: 20180147
    [Abstract] [Full Text] [Related]

  • 33. CD68(+)HLA-DR(+) M1-like macrophages promote motility of HCC cells via NF-κB/FAK pathway.
    Wang H, Wang X, Li X, Fan Y, Li G, Guo C, Zhu F, Zhang L, Shi Y.
    Cancer Lett; 2014 Apr 01; 345(1):91-9. PubMed ID: 24333724
    [Abstract] [Full Text] [Related]

  • 34. Cordycepin suppresses integrin/FAK signaling and epithelial-mesenchymal transition in hepatocellular carcinoma.
    Yao WL, Ko BS, Liu TA, Liang SM, Liu CC, Lu YJ, Tzean SS, Shen TL, Liou JY.
    Anticancer Agents Med Chem; 2014 Jan 01; 14(1):29-34. PubMed ID: 23855336
    [Abstract] [Full Text] [Related]

  • 35. 3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling.
    Li WX, Chen LP, Sun MY, Li JT, Liu HZ, Zhu W.
    Oncotarget; 2015 Sep 15; 6(27):23776-92. PubMed ID: 26068982
    [Abstract] [Full Text] [Related]

  • 36. Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites.
    Golubovskaya V, Kaur A, Cance W.
    Biochim Biophys Acta; 2004 May 25; 1678(2-3):111-25. PubMed ID: 15157737
    [Abstract] [Full Text] [Related]

  • 37. The histidine-rich calcium binding protein (HRC) promotes tumor metastasis in hepatocellular carcinoma and is upregulated by SATB1.
    Liu J, Han P, Li M, Yan W, Liu J, Liu J, He J, Tu W, Xia Y, Zhou Z, Gong J, Liu M, Ding Q, Tian D.
    Oncotarget; 2015 Mar 30; 6(9):6811-24. PubMed ID: 25762622
    [Abstract] [Full Text] [Related]

  • 38. Akebia trifoliata (Thunb.) Koidz Seed Extract inhibits human hepatocellular carcinoma cell migration and invasion in vitro.
    Lu WL, Yang T, Song QJ, Fang ZQ, Pan ZQ, Liang C, Jia DW, Peng PK.
    J Ethnopharmacol; 2019 Apr 24; 234():204-215. PubMed ID: 30528882
    [Abstract] [Full Text] [Related]

  • 39. Tumor Necrosis Factor-alpha utilizes MAPK/NFκB pathways to induce cholesterol-25 hydroxylase for amplifying pro-inflammatory response via 25-hydroxycholesterol-integrin-FAK pathway.
    Pokharel SM, Chiok K, Shil NK, Mohanty I, Bose S.
    PLoS One; 2021 Apr 24; 16(9):e0257576. PubMed ID: 34551004
    [Abstract] [Full Text] [Related]

  • 40. ASPP2 suppresses stem cell-like characteristics and chemoresistance by inhibiting the Src/FAK/Snail axis in hepatocellular carcinoma.
    Xu L, Tong X, Zhang S, Yin F, Li X, Wei H, Li C, Guo Y, Zhao J.
    Tumour Biol; 2016 Oct 24; 37(10):13669-13677. PubMed ID: 27473084
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.